
Raynham-based Medrobotics Corp., an emerging medical robotics company developing the innovative Flex™ Robotic System, announced today the conversion of notes totaling $33.6 Million purchased through recent financings into Series D Preferred Stock. Existing Medrobotics shareholders and undisclosed new investors participated in the Series D raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches next year in Europe and the United States.
“Patients, surgeons, and hospitals will all benefit from the Flex Robotic System’s enabling minimally invasive surgical technology,” said Samuel Straface, Ph.D., president and CEO of Medrobotics. “The Flex Robotic System will…

Robots and the Law
Top Transactions
All of the robotics industry’s top reported orders, sales, investments, mergers & acquisitions and financial events of 2012 now available in one downloadable doc!